KAI-7535
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for KAI-7535, covering 2026-01-29 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity [Phase 2]